European Commission logo
English English
CORDIS - EU research results
CORDIS

Biomedical engineering for cancer and brain disease diagnosis and therapy development

Objective

In the understanding of the initiation and development of several diseases revolutionary changes are currently taking place. Cancer and brain diseases are examples of medical fields where new technologies are finding their way into research and applications, radically altering the way the diseases are being diagnosed and treated. Especially methods that yield information on molecular and cellular mechanisms open up the way for novel effective therapies for disease prevention and disease curing.
The aim of this ITN is to conduct training and research in the field of novel bio-analytical methods and tools for cell based diseases, in specific for severe cancers and brain diseases. These methods and tools should allow faster and more reliable diagnosis, but are also of great importance for therapy research leading to novel treatment methods. This ITN combines disciplines such as engineering, biotechnology, medicine, and chip-technology and the consortium covers universities, hospitals and industry. The functionality of the devices is determined by the type of measurements that need to be performed, therefore we will focus on a few specific diseases: our cancer research will be aimed at skin cancer (melanoma) and blood cancer (leukaemia), and the part on brain diseases will focus on schizophrenia. Although we will direct our activities towards these three diseases in particular, we expect that the research (methods, devices, and technology) will also have impact on the understanding of other cancer types and other brain diseases.

Call for proposal

FP7-PEOPLE-2010-ITN
See other projects for this call

Coordinator

UNIVERSITAET BREMEN
EU contribution
€ 782 171,02
Address
Bibliothekstrasse 1
28359 Bremen
Germany

See on map

Region
Bremen Bremen Bremen, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Thomas Flink (Mr.)
Links
Total cost
No data

Participants (8)